Masahiro Sekiguchi

8.1k total citations · 2 hit papers
146 papers, 6.6k citations indexed

About

Masahiro Sekiguchi is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Masahiro Sekiguchi has authored 146 papers receiving a total of 6.6k indexed citations (citations by other indexed papers that have themselves been cited), including 73 papers in Molecular Biology, 24 papers in Genetics and 13 papers in Oncology. Recurrent topics in Masahiro Sekiguchi's work include DNA Repair Mechanisms (31 papers), Bacterial Genetics and Biotechnology (20 papers) and DNA and Nucleic Acid Chemistry (13 papers). Masahiro Sekiguchi is often cited by papers focused on DNA Repair Mechanisms (31 papers), Bacterial Genetics and Biotechnology (20 papers) and DNA and Nucleic Acid Chemistry (13 papers). Masahiro Sekiguchi collaborates with scholars based in Japan, United States and Somalia. Masahiro Sekiguchi's co-authors include Yusaku Nakabeppu, Kunihiko Sakumi, Teruhisa Tsuzuki, Harufumi Maki, Kazuki Nakao, Yohei Tominaga, Youichi Fujii, Aizo Matsushiro, Yasuhide Yoshimura and Kan Tanaka and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Masahiro Sekiguchi

141 papers receiving 6.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Targeted disruption of the Rad51 gene leads to lethality in embryonic mice.

1996 658 citations Teruhisa Tsuzuki, Masahiro Sekiguchi et al. profile →
Genes to cells edited by Jun-ichi Tomizawa, Blackwell Science Ltd. Institutional: £218.00 (Europe), £242.00 (Rest of World), US$382.00 (USA and Canada). Individual: £65.00 (Europe), £72.00 (Rest of World), US$114.00 (USA and Canada) ISSN 1356 9597

1997 619 citations Masahiro Sekiguchi profile →

Peers

Countries citing papers authored by Masahiro Sekiguchi

Since Specialization

Citations

This map shows the geographic impact of Masahiro Sekiguchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masahiro Sekiguchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masahiro Sekiguchi more than expected).

Fields of papers citing papers by Masahiro Sekiguchi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masahiro Sekiguchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masahiro Sekiguchi. The network helps show where Masahiro Sekiguchi may publish in the future.

Co-authorship network of co-authors of Masahiro Sekiguchi

This figure shows the co-authorship network connecting the top 25 collaborators of Masahiro Sekiguchi. A scholar is included among the top collaborators of Masahiro Sekiguchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masahiro Sekiguchi. Masahiro Sekiguchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Inhibition of the galactosyltransferase C1GALT1 reduces osteosarcoma cell proliferation by interfering with ERK signaling and cell cycle progression 2024 ·Cancer Gene Therapy ·Kentaro Watanabe, Keiji Tasaka, (unknown), Shota Kato, Hiroo Ueno, Katsutsugu Umeda, Tomoya Isobe, Yasuo Kubota, Masahiro Sekiguchi, Shunsuke Kimura, Aiko Sato‐Otsubo, Mitsuteru Hiwatari, Tetsuo Ushiku, Motohiro Kato, Akira Oka, Satoru Miyano, Seishi Ogawa, Junko Takita	4
2	Impact of Dapagliflozin on the Renal Function and Damage in Patients with Heart Failure with a Reduced Ejection Fraction 2023 ·Internal Medicine ·(unknown), (unknown), Yu Horiuchi, Masahiro Sekiguchi, Yusuke Watanabe, (unknown), Masahiko Asami, Kazuyuki Yahagi, Hitomi Yuzawa, Kota Komiyama, Jun Tanaka, Jiro Aoki, Kengo Tanabe	1
3	Malnutrition, hemodynamics and inflammation in heart failure with reduced, mildly reduced and preserved ejection fraction 2022 ·Heart and Vessels ·Yûsuke Watanabe, Yu Horiuchi, (unknown), (unknown), (unknown), Masahiro Sekiguchi, (unknown), (unknown), Masahiko Asami, Kazuyuki Yahagi, Kota Komiyama, Hitomi Yuzawa, Jun Tanaka, Jiro Aoki, Kengo Tanabe	7
4	Novel TENM3–ALK fusion is an alternate mechanism for ALK activation in neuroblastoma 2022 ·Oncogene ·Mitsuteru Hiwatari, Masafumi Seki, Ryosuke Matsuno, Kenichi Yoshida, (unknown), Aiko Sato‐Otsubo, Shohei Yamamoto, Motohiro Kato, Kentaro Watanabe, Masahiro Sekiguchi, Satoru Miyano, Seishi Ogawa, Junko Takita	4
5	Association of high-risk neuroblastoma classification based on expression profiles with differentiation and metabolism 2021 ·PLoS ONE ·Shunsuke Kimura, Masahiro Sekiguchi, Kentaro Watanabe, (unknown), Masafumi Seki, Kenichi Yoshida, Tomoya Isobe, Yusuke Shiozawa, Hiromichi Suzuki, N. Hoshino, Yasuhide Hayashi, Akira Oka, Satoru Miyano, Seishi Ogawa, Junko Takita	11
6	Description of longitudinal tumor evolution in a case of multiply relapsed clear cell sarcoma of the kidney 2021 ·Cancer Reports ·(unknown), Shunsuke Kimura, Masahiro Sekiguchi, Yasuo Kubota, Masafumi Seki, Kenichi Yoshida, Yuichi Shiraishi, Keisuke Kataoka, Yoichi Fujii, Kentaro Watanabe, Mitsuteru Hiwatari, Satoru Miyano, Seishi Ogawa, Junko Takita	3
7	3D integration technology with photosensitive mold for fan-out package 2021 ·Japanese Journal of Applied Physics ·K. Mori, (unknown), Masahiro Sekiguchi	0
8	Differential regulation of c-Met signaling pathways for synovial cell function 2014 ·SpringerPlus ·Seiji Shibasaki, Sachi Tsunemi, (unknown), Masahiro Sekiguchi, Hajime Sano, Tsuyoshi Iwasaki	12
9	Sphingosine 1-phosphate (S1P)/S1P receptor 1 signaling regulates receptor activator of NF-κB ligand (RANKL) expression in rheumatoid arthritis 2012 ·Biochemical and Biophysical Research Communications ·(unknown), Masayasu Kitano, Tsuyoshi Iwasaki, (unknown), Sachi Tsunemi, (unknown), Masahiro Sekiguchi, Naoto Azuma, Keiji Miyazawa, Timothy Hla, Hajime Sano	33
10	Modes of actions of two types of anti-neoplastic drugs, dacarbazine and ACNU, to induce apoptosis 2007 ·Carcinogenesis ·Masayuki Sanada, Masumi Hidaka, Yasuaki Takagi, Tomoyuki Takano, Yoshimichi Nakatsu, Teruhisa Tsuzuki, Masahiro Sekiguchi	32
11	Hepatocyte growth factor prevents lupus nephritis in a murine lupus model of chronic graft-versus-host disease 2006 ·Arthritis Research & Therapy ·T. Kuroiwa, Tsuyoshi Iwasaki, Takehito Imado, Masahiro Sekiguchi, Jiro Fujimoto, Hajime Sano	34
12	Sphingosine 1‐phosphate/sphingosine 1‐phosphate receptor 1 signaling in rheumatoid synovium: Regulation of synovial proliferation and inflammatory gene expression 2006 ·Arthritis & Rheumatism ·Masayasu Kitano, Timothy Hla, Masahiro Sekiguchi, Yutaka Kawahito, Rikio Yoshimura, Keiji Miyazawa, Tsuyoshi Iwasaki, Hajime Sano	141
13	CpG methylation of MGMT and hMLH1 promoter in hepatocellular carcinoma associated with hepatitis viral infection 2003 ·British Journal of Cancer ·Shiroh Matsukura, Hidenobu Soejima, (unknown), Hiroyuki Yakushiji, (unknown), (unknown), K. Miyazaki, Yusaku Nakabeppu, Masahiro Sekiguchi, T Mukai	49
14	Tissue distribution of prolactin-releasing peptide (PrRP) and its receptor 1999 ·Regulatory Peptides ·Ryo Fujii, Shoji Fukusumi, Masaki Hosoya, Yuji Kawamata, Yugo Habata, Shuji Hinuma, Masahiro Sekiguchi, Chieko Kitada, Tsutomu Kurokawa, Osamu Nishimura, Haruo Onda, Yasuhiro Sumino, Masahiko Fujino	95
15	Multi-forms of human MTH1 polypeptides produced by alternative translation initiation and single nucleotide polymorphism 1999 ·Nucleic Acids Research ·(unknown), Akinobu Taketomi, (unknown), R. Itoh, K Nishioka, Hiroyuki Yakushiji, T. Suzuki, Masahiro Sekiguchi, Yusaku Nakabeppu	45
16	A prolactin-releasing peptide in the brain 1998 ·Nature ·Shuji Hinuma, Yugo Habata, Ryo Fujii, Yuji Kawamata, Masaki Hosoya, Shoji Fukusumi, Chieko Kitada, Yoshinori Masuo, Tsuneo Asano, Hirokazu Matsumoto, Masahiro Sekiguchi, Tsutomu Kurokawa, Osamu Nishimura, Haruo Onda, Masahiko Fujino	458
17	Effects of Intracellular Cyclic AMP Modulators on Human Eosinophil Survival, Degranulation and CD11b Expression 1998 ·International Archives of Allergy and Immunology ·Tomoyasu Momose, Yoshio Okubo, Shiro Horie, Jun Suzuki, (unknown), Masahiro Sekiguchi	27
18	Molecular cloning of AtMMH, an Arabidopsis thaliana ortholog of the Escherichia coli mutM gene, and analysis of functional domains of its product 1998 ·Molecular and General Genetics MGG ·(unknown), Osamu Matsuda, Koh Iba, Isamu Terashima, Masahiro Sekiguchi, Yusaku Nakabeppu	67
19	Effect ofmutY andmutM/fpg-1 mutations on starvation-associated mutation inEscherichia coli: implications for the role of 7,8-dihydro-8-oxoguanine 1996 ·Molecular and General Genetics MGG ·(unknown), Masahiro Sekiguchi, Tatsurou Tajiri	52
20	[Restoration of ultraviolet-induced unsceduled DNA synthesis of xeroderma pigmentosum cells by insertion of T4 endonuclease V utilizing HVJ (AUTHOR'S TRANSL)]. 1976 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·Kan Tanaka, Yukinori Okada, Masahiro Sekiguchi	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact